🔎 Trials Near Me

Home › Kanser sa Gastrointestinal › Wisconsin

Pag-aaral pangklinika para sa Kanser sa Gastrointestinal sa Wisconsin

7 pag-aaral para sa Kanser sa Gastrointestinal ang naghahanap ng mga kalahok sa mga site sa Wisconsin.

Mga Lungsod sa Wisconsin

Opisyal na teksto ng pag-aaral (English)

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

  • GSK Investigational Site, Milwaukee
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07218926

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

  • Marshfield Clinic-Chippewa Center, Chippewa Falls
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay
  • at 1 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07215624

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
  • Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
  • Duluth Clinic Ashland, Ashland
  • at 29 pa
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07283939

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT06582017

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • University of Wisconsin- Madison, Madison
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.